MCLA-129 is under clinical development by Merus and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer. According to GlobalData, Phase II drugs for Paranasal Sinus And Nasal Cavity ...
Cellular Immunotherapy to Inhibit PD-L1 for Oncology is under clinical development by ImmunityBio and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer. According to GlobalData, Phase ...
Canine nasal tumors are a significant health concern in veterinary oncology, often leading to severe clinical symptoms and a challenging prognosis. Radiation therapy (RT) has emerged as a primary ...
It is relatively rare in the head and neck region, and no standard treatment has been established. Here, we report a case of primary neuroendocrine cancer of the nasal cavity in an elderly adult. This ...
Oral cavity cancer, often referred to as mouth cancer, is a serious health concern that affects hundreds of people globally. With a recent rise in the number of cases reported in India ...
What’s the reason for this? Your nasal cavity contains many blood vessels, which provide a more direct route for the drug into your bloodstream. When a drug is directly absorbed into your ...
The lesion was excised and measured 30 mm × 10 mm × 10 mm. At its attachment, a suspicious area of reticular pigmentation of the inferior turbinate and lateral wall of the nasal cavity was observed ...
PH284 nasal spray increased hunger in cancer cachexia patients, showing a 71% improvement in subjective hunger scores compared to baseline. The phase 2A study demonstrated PH284's safety, with no ...
This mucus buildup can become thick and encourage bacteria and other germs to build up in your sinus cavity, eventually leading to a sinus infection. A doctor typically asks about your symptoms ...